PMC:7402624 / 543-648 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T4","span":{"begin":19,"end":30},"obj":"Body_part"},{"id":"T5","span":{"begin":72,"end":77},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma84371"},{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"iral infection and plasmablast responses reaching \u003e30% of circulating B cells. However, another subgroup "}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T5","span":{"begin":5,"end":14},"obj":"Disease"}],"attributes":[{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"iral infection and plasmablast responses reaching \u003e30% of circulating B cells. However, another subgroup "}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T11","span":{"begin":70,"end":77},"obj":"http://purl.obolibrary.org/obo/CL_0000236"}],"text":"iral infection and plasmablast responses reaching \u003e30% of circulating B cells. However, another subgroup "}